Comparison of the effect of OABM WITH OABF regimens in In the treatment of Helicobacter pylori patients

Phase 3

Recruiting

• Conditions: helicobacter pylori (h. pylori) infection.; Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere; B96.81

• Registration Number: IRCT20150622022869N11
• Lead Sponsor: Yasouj University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

A patient who underwent endoscopy and has peptic ulcer disease (PUD).
Patients with dyspepsia without endoscopic indication have a positive Helicobacter diagnostic test, including Helicobacter stool antigen test and....
Patients with maltoma
Endoscopy patients with nud (non-ulcer dyspepsia) and patients with a history of cancer in their first degree relatives will be included in the study.
Patients who have a history of pud and are Helicobacter positive and are taking NSAID
Treatment-resistant dyspepsia
Patient satisfaction

Exclusion Criteria

Previous history of H pylori treatment
Allergy to antibiotics
Allergy to PPI
History of gastrectomy
Having gastric cancer
pregnant women
Taking antibiotics in the last month
Taking PPI or h2blocker in the last two weeks
Chronic liver, kidney or lung disease
History of Fauvism

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency distribution of Helicobacter pylori antigen negativity. Timepoint: 12weeks after the start of the study. Method of measurement: Stool antigen test.;Drug side effects. Timepoint: 12 weeks. Method of measurement: Clinical examination and patient presentation.